We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Gas Bubbles Used to Fight Tumors

By Biotechdaily staff writers
Posted on 03 Aug 2006
Researchers are experimenting with gas bubbles used like corks to block oxygen flow to tumors or to deliver drugs.

The process of blocking blood flow to a tumor is called embolization, and using gas bubbles is a new technique in embolotherapy. More...
What makes this method so promising is that the technique allows clinicians to control precisely where the bubbles are formed, so blockage of blood flow to surrounding tissue is minimal, according to Dr. Joseph Bull, assistant professor of biomedical engineering at the University of Michigan (U-M; Ann Arbor, USA).

The study of Dr. Bull and collaborator Dr. Brian Fowlkes, an associate professor in the department of radiology in the U-M Medical School, is currently focused on the vaporization and transport fundamentals that must first be determined to translate this developmental technique to the clinic.

In conventional embolotherapy techniques, the so-called cork that clinicians use to stop the blood flow--called an emboli--is solid. For instance, it could be a blood clot or a gel. A key problem with these approaches is restricting the emboli to the tumor to minimize destruction of surrounding tissue, without using very invasive procedures, according to Dr. Bull. The emboli must be delivered by a catheter placed into the body at the tumor site. Gas bubbles, however, allow very precise delivery because their formation can be controlled and directed from the outside, by focused high intensity ultrasound.

This planned technique is actually a two-step process, according to Dr. Bull. First, a flow of encapsulated superheated perfluorocarbon liquid droplets is delivered into the body by way of an intravenous injection. The droplets are small enough that they do not lodge in vessels. Clinicians image the droplets with conventional ultrasound, and once the droplets reach their destination, scientists blast them with high intensity ultrasound. The ultrasound acts like a pin popping a water balloon. After the shell pops, the perfluorocarbon expands into a gas bubble that is about 125 times larger in volume than the droplet.

"If a bubble remained spherical its diameter would be much larger than that of the vessel,” Dr. Bull said. "So it deforms into a long sausage-shaped bubble that lodges in the vessel like a cork. Two or three doses of bubbles will occlude most of the [blood] flow.” Without blood flow, the tumor dies. Because the bubble is so big, it is important to get the correct vessel in order not to damage it.

"How flexible the vessel is plays a very important role in where you do this,” Dr. Bull said. The embolotherapy study will be published in the August 2006 issue of the Journal of Biomechanical Engineering.

The technique could be very valuable in treating specific cancers, such as renal cancer and hepatocellular carcinoma, the most common form of liver cancer, which has a high mortality rate. However, cirrhosis of the liver makes it difficult to treat by the conventional method of excising the tumor and surrounding tissue, because so much of the liver is already damaged.



Related Links:
University of Michigan

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Pipette Calibration System
Artel PCS®
New
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.